Savannah Chrisley’s prescription weight loss website was flagged by the FDA over potentially misleading claims about GLP-1s.

GLP-1 drugs have been linked to everything from weight loss to a lower risk of developing cardiovascular disease, with new ...

Study of 600,000 US military veterans shows that those who took anti-obesity medications were less likely to develop some complications of substance-use disorders.

Submit an appeal, even if you’re worried you’ll lose. Yaver said that, based on the research set to be published in her book, Coverage Denied: How Health Insurers Drive Inequality in the United States ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Savannah caught the attention of the FDA. The post Savannah Chrisley Gets Warning From Feds Over Prescription Weight Loss ...

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.

RIVKIN Aesthetics reports the rise of weight loss drugs like GLP-1 is reshaping aesthetics, with many new patients seeking ...

The Malaysian Medical Association (MMA) reminds doctors to ensure every prescription and facility operating under their name reflects their professional responsibility.

The risk of the weight loss drug being prescribed outside its pharmaceutical indication was considered too high, while for children, the price was deemed inflated ...

The $166 ​bln Wegovy maker has ⁠effectively shed all ​its share-price gains ​from a pioneering obesity drug. The key problem: ​failing to ​build a vast supply chain ‌for ⁠a remedy that could treat 1 ...